Newly discovered signaling loop is shown to be druggable
New clinical trials size up an immunomodulator’s pleiotropic effects
Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition
Grant enables pooling of genomics, molecular medicine, animal models, advanced neuroimaging
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New study aims to assess a potential new indication for the technology
Study looks for correlations in neurology research
Focus is on inhibiting action of myeloid-derived suppressor cells
Extension study of VMAT2 inhibitor helps confirm a new therapeutic era
NIH-funded clinical study pairs up two innovative techniques
Interdisciplinary research aims to glean insights for therapeutic translation
Advertisement
Advertisement